Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
Date:1/24/2013
SAN DIEGO, Jan. 24, 2013 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended December 31, 2012. Revenue for the quarter ended December 31, 2012 was $376.5 million, a 13% increase (a 14% increase on a constant currency basis) over the quarter ended December 31, 2011. For the quarter ended December 31, 2012, net income was $77.9 million, an increase of 24% compared to the quarter ended December 31, 2011. Diluted earnings per share for the quarter ended December 31, 2012 were $0.53, an increase of 26% compared to the quarter ended December 31, 2011.
(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)
SG&A expenses were $107.8 million for the quarter ended December 31, 2012, an increase of 7% (an 8% increase on a constant currency basis) over the quarter ended December 31, 2011. The increase in SG&A was primarily due to expenses necessary to support sales growth. SG&A costs were 28.6% of revenue in the quarter ended December 31, 2012, compared to 30.2% in the quarter ended December 31, 2011.R&D expenses were $30.3 million for the quarter ended December 31, 2012, or 8.1% of revenue. R&D expenses increased by 11% (also an 11% increase on a constant currency basis) compared to the quarter ended December 31, 2011.
The company amortized acquired intangibles of $2.5 million ($1.9 million, net of tax) during the quarter ended December 31, 2012. Stock-based compensation costs incurred during the quarter ended December 31, 2012 of $9.5 million ($6.5 million, net of tax) consisted of expenses associated with stock options, restricted stock units, and our employee stock purchase plan.
For the six months ended December 31, 2012, revenue was $716.3 million, an increase
'/>"/>
| SOURCE ResMed Inc. Copyright©2012 PR Newswire. All rights reserved |
Related medicine technology :
1. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
2. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
3. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
4. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
5. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
6. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
7. Metabolic Solutions Development Company announces publication of Phase 2b data in Clinical Pharmacology & Therapeutics
8. Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.
9. Harwood Feffer LLP Announces Investigation of MAP Pharmaceuticals, Inc.
10. VWR Funding, Inc. Announces Proposed Offering Of Senior Secured Term Loan Due 2017
11. FDAnews announces Biopharmaceutical Good Distribution Practices Summit
Post Your Comments:
(Date:6/18/2013)... INDIANAPOLIS , June 18, 2013 ... partnership with Aegis Health Group to ... Aegis workforce wellness programs administered by health systems ... system, manufactured by PTS and distributed through ... for total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, ...
(Date:6/17/2013)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... 2013, the Endocrine Society,s 95 th Annual ... melatonin and cortisol rhythms. This effect further confirms ... and address the circadian desynchrony which is inherent ... Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study of ...
(Date:6/17/2013)... 2013 DNAtrix Inc., experts in oncolytic virus ... data on the company,s lead product, DNX-2401, at the ... City, Canada on June 18, 2013. ... a leader in the field of oncolytic virus therapy, ... PHASE I TRIAL OF A CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS DNX-2401 ...
Breaking Medicine Technology:Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2[0] Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients[0] Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder[0] DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus
... , , , ... Americans could be newly eligible for statin therapy if findings from ... That could take the number of older adults ... of that population. , The ...
... respond to agency during first quarterKENILWORTH, N.J., Jan. 14 ... announced that the U.S. Food and Drug Administration (FDA) ... sublingual tablets in the acute treatment of schizophrenia in ... mixed episodes associated with bipolar I disorder in adults ...
Cached Medicine Technology:New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy 2New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy 3New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy 4New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy 5U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder 2(Date:6/18/2013)... SEATTLE, WA—A Washington state resident filed a lawsuit ... fell ill with a hepatitis A infection after eating ... The complaint was filed in Snohomish County Superior Court ... firm that has filed 14 previous lawsuits against ... Brothers consumed “Townsend Farms Organic Antioxidant Blend” on multiple ...
(Date:6/18/2013)... Horsham, PA (PRWEB) June 18, 2013 Senior ... in Boston on June 25 to discuss—for the first time ... agencies in getting drugs through the regulatory process in a ... of drug evaluation will share respective best practices and processes ... Across the Strait panel at the DIA 2013 ...
(Date:6/18/2013)... Sun Buick GMC, Moosic, is sponsoring the hole-in-one contest at ... on Thursday, June 20, at Irem Country Club, Dallas, Pennsylvania. ... Verano and will go to the lucky golfer at the ... , The MFHS golf tournament is open to all interested ... crew team for 18 holes. The fee is $125 per ...
(Date:6/18/2013)... Center clinical researchers have launched an innovative clinical ... the ability of a patient,s own stem cells ... arterial disease (PAD). , Led by Vik ... Hospitals Case Medical Center,s Harrington Heart & Vascular ... Reserve University School of Medicine, the clinical trial ...
(Date:6/18/2013)... The July 2013 issue of Marie Claire ... Beach Ready,” offers a list of home and doctor’s office ... a bathing suit this summer. The list includes treatment options ... smoothing cellulite , and more. (go to goo.gl/aIe4J). , “It’s ... Epione Beverly Hills, “though I would say some of the ...
Breaking Medicine News(10 mins):Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Skin Care – Getting Your Body Beach Ready 2[0] Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A[0] Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting[0] Sun Buick GMC Sponsors Hole-In-One Contest For Maternal and Family Health Services Golf Tournament[0] UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation[0] Skin Care – Getting Your Body Beach Ready
... with Attention Deficit Hyperactivity Disorder - ADHD - ... with decision-making, thinking and planning. The abnormality was ... researchers to look at the brains of children ... of Child Psychiatry at the Medical Research Council, ...
... and Drug Administration agreed that an ingredient commonly used ... recommend further review by the FDA. ,The FDA ... five-year study by Yale University researchers that found phenyl-propanolamine ... the risk of stroke in some users. PPA helps ...
... a degenerative brain disease that usually begins gradually, ... familiar tasks. The disease eventually leads// to confusion, ... becomes more difficult as the disease progresses, leaving ... or follow directions. Eventually, most people with Alzheimer’s ...
... way to predict when somebody is likely to have ... occur suddenly and without warning and can lead to ... de la Pitie-Salpetriere, Paris, believe ,it may be possible ... an electroencephalogram ,(EEG). ,An ECG records electrical activity ...
... may allow treatment at a later stage than other ... the market for a decade in Germany// and was ... of the Food and Drug Administration. ... approved Alzheimer's drugs, such as Aricept, that have been ...
... Women are more prone to get depression during their pregnancy ... for depression was 32 weeks// into pregnancy, close to birth. ... a rise in stress hormones could lead to low birth ... the Avon area, whose babies were due between April 1 ...
Cached Medicine News:... designed specifically for the Palm Organizers ... ward rounds. It is intended to ... consultations that are requested by the ... Ward round examinations and to record ...
... tracking and billing. This ... Handheld application, a complete ... CPT™ and ICD-9-CM codes ... Designed for any medical ...
In addition to the patient data OB-on-Call contains a comprehensive Medications list displaying related drugs by brand name, generic title, and usage description notes....
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |